Cargando…

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies

P. aeruginosa is classified as a priority one pathogen by the World Health Organisation, and new drugs are urgently needed, due to the emergence of multidrug-resistant (MDR) strains. Antimicrobial-resistant nosocomial pathogens such as P. aeruginosa pose unwavering and increasing threats. Antimicrob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langendonk, R. Frèdi, Neill, Daniel R., Fothergill, Joanne L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085337/ https://www.ncbi.nlm.nih.gov/pubmed/33937104 http://dx.doi.org/10.3389/fcimb.2021.665759

Ejemplares similares

In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
por: Spottiswoode, Natasha, et al.
Publicado: (2023)

Mechanism of resistance to phagocytosis and pulmonary persistence in mucoid Pseudomonas aeruginosa
por: Rowe, Warren J., et al.
Publicado: (2023)

Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical Pseudomonas aeruginosa isolates from Switzerland
por: Babouee Flury, Baharak, et al.
Publicado: (2023)

Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2019)

Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
por: Liao, Chongbing, et al.
Publicado: (2022)

Pseudomonas aeruginosa Infection Modulates the Immune Response and Increases Mice Resistance to Cryptococcus gattii
por: Peres-Emidio, Eluzia C., et al.
Publicado: (2022)

The Long-Term Effect of a Nine Amino-Acid Antimicrobial Peptide AS-hepc3((48-56)) Against Pseudomonas aeruginosa With No Detectable Resistance
por: Zhu, Depeng, et al.
Publicado: (2021)

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases
por: Zhen, Sisi, et al.
Publicado: (2023)

Genomic Characterization of Mutli-Drug Resistant Pseudomonas aeruginosa Clinical Isolates: Evaluation and Determination of Ceftolozane/Tazobactam Activity and Resistance Mechanisms
por: Bitar, Ibrahim, et al.
Publicado: (2022)

Novel Chromosome-Borne Accessory Genetic Elements Carrying Multiple Antibiotic Resistance Genes in Pseudomonas aeruginosa
por: Yu, Ting, et al.
Publicado: (2021)

Editorial: Pseudomonas aeruginosa Pathogenesis: Virulence, Antibiotic Tolerance and Resistance, Stress Responses and Host-Pathogen Interactions
por: Rossi, Elio, et al.
Publicado: (2022)

Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
por: Patil, Sandip, et al.
Publicado: (2023)

Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
por: Sophonsri, Anthony, et al.
Publicado: (2023)

Phage vB_PaeS-PAJD-1 Rescues Murine Mastitis Infected With Multidrug-Resistant Pseudomonas aeruginosa
por: Wang, Zhaofei, et al.
Publicado: (2021)

Editorial: Current Perspectives of Antimicrobial Resistance in Campylobacteraceae and Helicobacteraceae
por: Levican, Arturo, et al.
Publicado: (2022)

Editorial: Antimicrobial resistance in pediatric infectious diseases: antimicrobial resistance, resistance mechanisms and antimicrobial use
por: Yu, Dingle, et al.
Publicado: (2023)

Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in Pseudomonas aeruginosa in a Murine Biofilm Wound Model
por: Laulund, Anne S., et al.
Publicado: (2021)

Itaconimides as Novel Quorum Sensing Inhibitors of Pseudomonas aeruginosa
por: Fong, July, et al.
Publicado: (2019)

Effects of daphnetin on biofilm formation and motility of pseudomonas aeruginosa
por: Ye, Zuoji, et al.
Publicado: (2022)

PM(10) and Pseudomonas aeruginosa: effects on corneal epithelium
por: Somayajulu, Mallika, et al.
Publicado: (2023)

Acquisition of resistance to ceftazidime-avibactam during infection treatment in Pseudomonas aeruginosa through D179Y mutation in one of two bla(KPC-2) gene copies without losing carbapenem resistance
por: García, Patricia, et al.
Publicado: (2022)

Contribution of Short Chain Fatty Acids to the Growth of Pseudomonas aeruginosa in Rhinosinusitis
por: Cho, Do-Yeon, et al.
Publicado: (2020)

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
por: Fraser-Pitt, Douglas J., et al.
Publicado: (2021)

Contribution of Pseudomonas aeruginosa Exopolysaccharides Pel and Psl to Wound Infections
por: Fleming, Derek, et al.
Publicado: (2022)

ExlA: A New Contributor to Pseudomonas aeruginosa Virulence
por: Huber, Philippe
Publicado: (2022)

Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa
por: Kang, Yixin, et al.
Publicado: (2023)

Multidrug-resistant Pseudomonas aeruginosa is predisposed to lasR mutation through up-regulated activity of efflux pumps in non-cystic fibrosis bronchiectasis patients
por: Ding, Fengming, et al.
Publicado: (2022)

Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice
por: Kang, Jason, et al.
Publicado: (2023)

Biofilm Formation by Pseudomonas aeruginosa in a Novel Septic Arthritis Model
por: Li, Dingbin, et al.
Publicado: (2021)

A Commensal Streptococcus Dysregulates the Pseudomonas aeruginosa Nitrosative Stress Response
por: Baty, Joshua J., et al.
Publicado: (2022)

Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system
por: Jouault, Albane, et al.
Publicado: (2022)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
por: Horspool, Alexander M., et al.
Publicado: (2023)

Commensal colonization reduces Pseudomonas aeruginosa burden and subsequent airway damage
por: Stoner, Sara N., et al.
Publicado: (2023)

Editorial: Women in antimicrobial resistance and new antimicrobial drugs
por: Wozniak, Rachel A. F., et al.
Publicado: (2023)

The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph(12−38) With Antibiotics Azithromycin and Rifampicin Enhances Bactericidal Activity Against Pseudomonas Aeruginosa
por: Liu, Jie, et al.
Publicado: (2020)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)

Glutathione Activates Type III Secretion System Through Vfr in Pseudomonas aeruginosa
por: Zhang, Yani, et al.
Publicado: (2019)

In vitro Interaction of Pseudomonas aeruginosa Biofilms With Human Peripheral Blood Mononuclear Cells
por: Kaya, Esingül, et al.
Publicado: (2020)

Quorum Sensing Inhibiting Activity of Cefoperazone and Its Metallic Derivatives on Pseudomonas aeruginosa
por: Naga, Nourhan G., et al.
Publicado: (2021)

Comparative genomics and DNA methylation analysis of Pseudomonas aeruginosa clinical isolate PA3 by single-molecule real-time sequencing reveals new targets for antimicrobials
por: Li, Zijiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhh5fai4022jhu5asan7np441n